AZPIL
Sebi censures Astrazeneca Pharma's promoter, Elliot GroupReason: professional misconduct and unfair trade practices during delisting plan in 2014.
Sun Pharma, AstraZeneca seal distribution dealThe drug majors have entered into a distribution services agreement to distribute AstraZeneca's heart disease treatment drug 'Axcer' in Ind...
AstraZeneca stake-sale plan raises eyebrowsSince early last year, AZPIL has been on an upswing, doubling in value to a peak of Rs 2,598 on April 12 on the delisting buzz.
- Load More